Navigation Links
Resverlogix desincorpora RVX Therapeutics Inc. para sus accionistas
Date:4/8/2013

ting dates are anticipated to be on or around April 25, 2013 and May 28, 2013, respectively. A management information circular containing a complete description of the Arrangement and a description of tax implications to shareholders will be sent to shareholders of Resverlogix in connection with the special meeting to approve the Arrangement.

No se podrá asegurar o garantizar que la desincorporación se lleve a cabo.

Resverlogix celebrará una rueda de prensa en directo y emisión web con preguntas y respuestas a las 11 a.m. MDT del 8 de abril de 2013.

Enlace a la emisión web:

http://services.choruscall.ca/links/resverlogix130408.html

Números de llamada de la rueda de prensa:

Canadá y Estados Unidos, número gratuito: 1-800-319-4610

Fuera de Canadá y Estados Unidos llame al número: +1-604-638-5340

Acerca de Resverlogix Corp.

Resverlogix Corp. (TSX:RVX) es una compañía cardiovascular en fase clínica con una tecnología de plataforma epigenética que modula la producción de proteína. Resverlogix está desarrollando RVX-208, una molécula pequeña de primera clase para el tratamiento de la ateroesclerosis. RVX-208 es el primer inhibidor de bromodominio BET en ensayos clínicos. Los nuevos compuestos que surgen de la plataforma de descubrimiento de fármaco epigenético de Resverlogix funcionan por medio de la inhibición de los bromodominios BET, y cuentan con el potencial para impactar en múltiples enfermedades, incluyendo el cáncer, enfermedades neurodegenerativas y diabetes mellitus. Las acciones ordinarias de Resverlogix Corp. cotizan en la Bolsa de Valores de Toronto (TSX: RVX). Si desea más información visite la página web http://www.res
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
3. Aratana Therapeutics Adds To Drug Development Team
4. Biovista und DART Therapeutics nehmen Zusammenarbeit auf, um auf Duchenne-Muskeldystrophie abzielende Medikamente neu zu positionieren
5. Novira Therapeutics Completes $25 Million Series A Financing
6. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
7. Pain Therapeutics - Drugs, Markets and Companies - 2013 Report
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
10. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
11. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property ... intellectual property, today announced a litigation update. ... Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, in ... of Virginia , the Court issued ... key claims in favor of the Defendants on the ...
(Date:7/1/2015)... and PARIS , July 1, ... Genective, key developer of biotech crops, today announce ... new generations of insect control traits. ... counter the realities of advancing insect resistance. We ... unique insect control technology with Genective,s capability in ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical ... new Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. ... that will increase healthcare worker safety and reduce financial costs. , CTI Electronics ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... July 8 Knowledge Enterprises, Inc.,and The ... of The,2007-2008 Orthopaedic Industry Annual Report, the ... data. The nearly 200,page Annual Report summarizes ... Joint Replacement, Fracture Repair, Arthroscopy/Soft,Tissue Repair, Spinal ...
... 8 Telik, Inc.,(Nasdaq: TELK ), today ... Chemistry Letters describing a novel class of small ... treatment for diabetes.,These unique compounds are the result ... optimize the original lead structure identified through,the application ...
... US-made bulk API, BATON ROUGE, La., ... (NYSE: ALB ), a leading global ... active pharmaceutical,ingredients (APIs), has signed a global ... As per the agreement, effective,immediately, Albemarle has ...
Cached Biology Technology:Knowledge Enterprises, Inc. and The Institute for Orthopaedics(TM) Release The 2007-2008 Orthopaedic Industry Annual Report 2Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters 2Albemarle Enters Ibuprofen Agreement with Dr. Reddy's 2Albemarle Enters Ibuprofen Agreement with Dr. Reddy's 3
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... with the gradual acidification of the world,s oceans than previously ... escape climatic devastation. In new research published in the ... has identified a powerful internal mechanism that could enable some ... of a more acidic ocean. As humans release ever-larger ...
... , Radioactive iodine found by Dartmouth researchers in the ... a nuclear reactor,s explosion and meltdown half a world ... Department of Earth Science. The failure of the Fukushima ... earthquake and tsunami, was the largest nuclear disaster since ...
... be no accident when doctors observe how patients suffering ... more aggressive cancer. However, the new-found interaction between the ... A potential relationship between metastatic breast cancer and ... led researchers from the University of North Carolina at ...
Cached Biology News:Corals 'could survive a more acidic ocean' 2Corals 'could survive a more acidic ocean' 3Dartmouth scientists track radioactive iodine from Japan nuclear reactor meltdown 2Dartmouth scientists track radioactive iodine from Japan nuclear reactor meltdown 3Mechanism found connecting metastatic breast cancer and arthritis 2Mechanism found connecting metastatic breast cancer and arthritis 3
Goat polyclonal to Glucose Dehydrogenase ( Abpromise for all tested applications). Antigen: Glucose Dehydrogenase (Bacillus species)...
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
Acetyl-Histone H2B (Lys20) Antibody...
Biology Products: